Guobang Pharma Ltd.
SSE:605507.SS
20.53 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| 780.577 | 612.464 | 920.622 | 706.23 | 810.288 | 494.008 | 483.458 | 391.245 |
| Depreciation & Amortization
| 433.38 | 322.373 | 258.334 | 201.123 | 157.114 | 138.346 | 132.153 | 115.52 |
| Deferred Income Tax
| 0 | 0 | 20.2 | -5.535 | -0.756 | 8.23 | -4.418 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -539.568 | -433.915 | -183.163 | -1,170.723 | -284.934 | -213.67 | -170.142 | -444.205 |
| Accounts Receivables
| -634.306 | -929.354 | -255.525 | -841.806 | -51.431 | 45.904 | 233.361 | -359.532 |
| Inventory
| -20.68 | 9.201 | -127.53 | -371.614 | -157.22 | 6.219 | -293.279 | -202.453 |
| Accounts Payables
| 0 | 488.705 | 179.692 | 48.233 | -75.527 | -274.023 | -105.806 | 0 |
| Other Working Capital
| 115.418 | -2.467 | 20.2 | -5.535 | -0.756 | 8.231 | 123.137 | -241.752 |
| Other Non Cash Items
| 32.021 | 15.839 | 21.242 | 87.188 | 85.237 | 22.179 | 96.214 | 85.472 |
| Operating Cash Flow
| 706.411 | 516.761 | 1,017.034 | -176.183 | 767.705 | 440.864 | 541.683 | 148.033 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -419.125 | -748.441 | -803.115 | -448.044 | -520.159 | -605.181 | -163.245 | -169.477 |
| Acquisitions Net
| 0 | 0 | 17.813 | 4.337 | 1.728 | -8.28 | -20 | 4.938 |
| Purchases Of Investments
| -5,418.524 | -987.482 | -3,157.785 | -3,091.003 | -421 | -1,237 | -738.314 | -441.767 |
| Sales Maturities Of Investments
| 5,305.845 | 1,349.557 | 3,531.323 | 1,844.874 | 575.47 | 1,384.502 | 591.548 | 517.493 |
| Other Investing Activites
| 17.957 | 33.102 | 0 | 0 | -1.272 | 158.617 | 183.82 | 11.614 |
| Investing Cash Flow
| -513.846 | -353.265 | -411.764 | -1,689.836 | -365.232 | -307.342 | -146.191 | -77.199 |
| Financing Activities: | ||||||||
| Debt Repayment
| -189.079 | 307.5 | 495.115 | -750.3 | -63.788 | 231.536 | -102.123 | -10.587 |
| Common Stock Issued
| 0 | 0 | 0 | -22.177 | -5.047 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 22.177 | 5.047 | 0 | 0 | 0 |
| Dividends Paid
| -194.101 | -361.636 | -111.765 | -279.412 | -152 | -34.061 | -31.349 | -46.405 |
| Other Financing Activities
| -3.313 | 0 | 0.054 | 2,676.735 | -53.024 | -244.493 | -80.772 | -40.759 |
| Financing Cash Flow
| -386.494 | -54.136 | 366.954 | 1,570.519 | -273.859 | -47.017 | -214.245 | -97.752 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 27.076 | 10.706 | 35.269 | -9.932 | -32.612 | 5.444 | 8.319 | -17.223 |
| Net Change In Cash
| -166.853 | 120.066 | 1,007.493 | -305.432 | 96.001 | 91.948 | 189.566 | -44.141 |
| Cash At End Of Period
| 1,534.372 | 1,701.225 | 1,581.159 | 573.666 | 879.098 | 783.097 | 691.149 | 501.583 |